STOCKHOLM, Feb. 9, 2021 /PRNewswire/ -- On Tuesday February 16, at 16.00 CET, IRRAS will
host a conference call and an online presentation of its Q4 2020
interim report (which will have been published earlier on the
16th at 08.00 CET). The presentation will be held in
English.
The dial-in numbers for the conference call are:
Sweden: +46 8 56 64 27
03
Rest of the world: +44 33 33 00 92 71
The presentation will be webcast and can be accessed from the
following web address:
https://tv.streamfabriken.com/irras-q4-2020
Speakers: CEO Kleanthis G.
Xanthopoulos, Ph.D., President and CCO Will Martin and CFO
Sabina Berlin
About IRRAS
IRRAS is a global medical care company focused on delivering
innovative medical solutions to improve the lives of critically ill
patients. IRRAS designs, develops, and commercializes neurocritical
care products that transform patient outcomes and decrease the
overall cost of care by addressing complications associated with
current treatment methodologies. IRRAS markets and sells its
comprehensive, innovative IRRAflow and Hummingbird ICP Monitoring
product lines to hospitals worldwide through its direct sales
organization in the United States
and select European countries as well as an international network
of distribution partners.
IRRAS maintains its headquarters in Stockholm, Sweden, with corporate offices in
Munich, Germany, and San Diego, California, USA. For more
information, please visit www.irras.com.
IRRAS AB (publ) is listed on Nasdaq Stockholm (ticker:
IRRAS).
For more information, please contact:
USA
Kleanthis G. Xanthopoulos,
Ph.D.
CEO
ir@irras.com
Europa
Sabina Berlin
CFO
+46 73 951 95 02
sabina.berlin@irras.com
The information was released for public disclosure, through
the agency of the contact person above, on February 9, 2020 at 08:00 (CET).
This information was brought to you by Cision
http://news.cision.com
https://news.cision.com/irras/r/q4-report-2020---invitation-to-conference-call-and-audiocast,c3282290